ID   GM23338
AC   CVCL_F182
AS   CVCL_A0ZT
SY   GM23338*B; PGP1 iPSC; PGP1-iPS; PGP1 hiPSC; PGP1-1; PGP1; HVRDi004-B; UMi031-A
DR   EFO; EFO_0007950
DR   BioSample; SAMN00211020
DR   BioSample; SAMN03485859
DR   Coriell; GM23338
DR   ENCODE; ENCBS368AAA
DR   ENCODE; ENCBS373AAA
DR   GEO; GSM1019346
DR   GEO; GSM1019347
DR   GEO; GSM1658378
DR   GEO; GSM2072609
DR   GEO; GSM2072610
DR   hPSCreg; HVRDi004-B
DR   SKIP; SKIP000178
DR   SKIP; SKIP004355
DR   Wikidata; Q54853011
RX   PubMed=19911041;
RX   PubMed=26004630;
RX   PubMed=34352618;
RX   PubMed=36459969;
WW   Info; PGP; hu43860C; https://my.pgp-hms.org/profile_public?hex=hu43860C
CC   Part of: Personal Genome Project (PGP) cell line collection.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F183 ! GM23248
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
RX   PubMed=19911041; DOI=10.1371/journal.pgen.1000718; PMCID=PMC2766639;
RA   Lee J.-H., Park I.-H., Gao Y., Li J.B., Li Z., Daley G.Q., Zhang K.,
RA   Church G.M.;
RT   "A robust approach to identifying tissue-specific gene expression
RT   regulatory variants using personalized human induced pluripotent stem
RT   cells.";
RL   PLoS Genet. 5:e1000718.1-e1000718.15(2009).
//
RX   PubMed=26004630; DOI=10.1016/j.stemcr.2015.04.009; PMCID=PMC4471828;
RA   Tanaka Y., Hysolli E., Su J., Xiang Y.-F., Kim K.-Y., Zhong M., Li Y.-M.,
RA   Heydari K., Euskirchen G., Snyder M.P., Pan X.-H., Weissman S.M.,
RA   Park I.-H.;
RT   "Transcriptome signature and regulation in human somatic cell
RT   reprogramming.";
RL   Stem Cell Reports 4:1125-1139(2015).
//
RX   PubMed=34352618; DOI=10.1016/j.scr.2021.102474;
RA   Nourbakhsh A., Gosstola N.C., Fernandez-Valle C., Dykxhoorn D.M.,
RA   Liu X.-Z.;
RT   "Characterization of UMi031-A-2 inducible pluripotent stem cell line
RT   with a neurofibromatosis type 2-associated mutation.";
RL   Stem Cell Res. 55:102474-102474(2021).
//
RX   PubMed=36459969; DOI=10.1016/j.stem.2022.11.004; PMCID=PMC9782786;
RA   Pantazis C.B., Yang A., Lara E., McDonough J.A., Blauwendraat C.,
RA   Peng L.-R., Oguro H., Kanaujiya J., Zou J.-Z., Sebesta D., Pratt G.,
RA   Cross E., Blockwick J., Buxton P., Kinner-Bibeau L.B., Medura C.,
RA   Tompkins C., Hughes S., Santiana M., Faghri F., Nalls M.A., Vitale D.,
RA   Ballard S., Qi Y.A., Ramos D.M., Anderson K.M., Stadler J.,
RA   Narayan P., Papademetriou J., Reilly L., Nelson M.P., Aggarwal S.,
RA   Rosen L.U., Kirwan P., Pisupati V., Coon S.L., Scholz S.W., Priebe T.,
RA   Ottl M., Dong J., Meijer M., Janssen L.J.M., Lourenco V.S.,
RA   van der Kant R., Crusius D., Paquet D., Raulin A.-C., Bu G.-J., Held A.,
RA   Wainger B.J., Gabriele R.M.C., Casey J.M., Wray S., Abu-Bonsrah K.D.,
RA   Parish C.L., Beccari M.S., Cleveland D.W., Li E., Rose I.V.L.,
RA   Kampmann M., Calatayud Aristoy C., Verstreken P., Heinrich L.,
RA   Chen M.Y., Schule B., Dou D., Holzbaur E.L.F., Zanellati M.C.,
RA   Basundra R., Deshmukh M., Cohen S., Khanna R., Raman M., Nevin Z.S.,
RA   Matia M., Van Lent J., Timmerman V., Conklin B.R., Chase K.J.,
RA   Zhang K., Funes S., Bosco D.A., Erlebach L., Welzer M.,
RA   Kronenberg-Versteeg D., Lyu G.-C., Arenas E., Coccia E., Sarrafha L.,
RA   Ahfeldt T., Marioni J.C., Skarnes W.C., Cookson M.R., Ward M.E.,
RA   Merkle F.T.;
RT   "A reference human induced pluripotent stem cell line for large-scale
RT   collaborative studies.";
RL   Cell Stem Cell 29:1685-1702.e22(2022).
//